Riskpilot← Back to searchSign inGet full accessLiponovo Oy
OYDissolvedY-tunnus 3150367-1Lapinlahdenkatu 16Muu luonnontieteellinen ja tekninen tutkimus ja kehitt. · NACE 72190Est. 2020— employeeswww.linio-biotech.com
Revenue 2023
EUR -62K
EBITDA margin
103.4%
+9% vs 2022
Equity ratio
-385.1%
Financial strength
Net profit 2023
EUR -66K
+9% vs 2022
| Revenue | EUR -62K | — |
| EBITDA | EUR -64K | +9% |
| Net profit | EUR -66K | +9% |
| Total assets | EUR 37K | -30% |
| Equity | EUR -141K | -521% |
| Employees | — | — |
Legal name
Liponovo Oy
Y-tunnus number
3150367-1
Legal form
Osakeyhtiö
NACE code
72190 · Muu luonnontieteellinen ja tekninen tutkimus ja kehitt.
Founded
3. elokuuta 2020
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-08-28
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Kudoslaitos, jonka tehtävänä on ihmiskudoksen hankinta, testaus, talteenotto, säilöminen, säilytys, käsittely ja jakelu
Address
Lapinlahdenkatu 16
Phone
+358503878119
Email
info@linio-biotech.com
Website
www.linio-biotech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 0 | 0 | −62 |
| Staff expenses | — | — | −0 |
| EBITDA | −3 | −71 | −64 |
| Depreciation & amort. | — | — | −0 |
| EBIT | −3 | −71 | −64 |
| Net financials | — | −2 | −2 |
| Profit before tax | −3 | −72 | −66 |
| Tax | −0 | −0 | −0 |
| Net profit | −3 | −72 | −66 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 106 | 53 | 37 |
| Equity | −3 | 34 | −141 |
| Long-term debt | 109 | — | 169 |
| Short-term debt | 0 | 19 | 9 |
| Total debt | 109 | 19 | 178 |
EBITDA margin
-6394100.0%
This company
15.8%
Market median
-40469087% vs market
20212023
Equity ratio
-385.1%
This company
38.2%
Market median
-1108% vs market
20212023
Return on equity
-6588400.0%
This company
18.4%
Market median
-35806622% vs market
20212023
Net profit margin
-6588400.0%
This company
8.1%
Market median
-81338372% vs market
20212023
Asset turnover
-1.69×
This company
1.12×
Market median
-251% vs market
20212023
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20212023
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TJ Deputy Member | Deputy Member | 2021 |
AK Audit | Audit | 2023 |
JA Deputy auditor | Deputy auditor | 2023 |
| Former (1) | ||
IO Deputy Member | Deputy Member | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Liponovo Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Jaakko Ylikomi | Deputy Member | 0 companies |
| Ilkka Olavi Malka | Deputy Member | 0 companies |
| Ari-Matti Korkeamäki | Audit | 0 companies |
| Jose Adam Juhani Kautonen | Deputy auditor | 0 companies |
| Karita Hannele Reijonsaari | Chairperson | 0 companies |
| Jertta-Riina Anniina Uusmies | Board of Directors | 0 companies |
| Matti Jaakoppi Lehtipuu | Board of Directors | 0 companies |